Cerebrospinal fluid amyloid-β and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients

Cerebrospinal fluid amyloid-β and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients

Abstract Background Neuropsychiatric symptoms (NPS) are prevalent in cognitively impaired individuals including Alzheimer’s disease (AD) dementia and mild cognitive impairment (MCI). Whereas several studies have reported the associations between NPS with AD pathologic biomarkers and cerebral small v...

Full description

Bibliographic Details
Main Authors: Qingze Zeng, Yanbo Wang, Shuyue Wang, Xiao Luo, Kaicheng Li, Xiaopei Xu, Xiaocao Liu, Luwei Hong, Jixuan Li, Zheyu Li, Xinyi Zhang, Siyan Zhong, Zhirong Liu, Peiyu Huang, Yanxing Chen, Minming Zhang, for behalf of Alzheimer’s Disease Neuroimaging Initiative
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Neuropsychiatry
Amyloid
Small vessel disease
Biomarkers
Online Access:https://doi.org/10.1186/s13195-024-01434-7

Internet

https://doi.org/10.1186/s13195-024-01434-7

Similar Items